Literature DB >> 1244550

Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.

W G Robertson, M Peacock, R W Marshall, D H Marshall, B E Nordin.   

Abstract

Studies were carried out on multiple urine samples from eight patients with recurrent idiopathic calcium oxalate stone formation and eight normal persons to define an index of the risk of forming calcium oxalate stones. Under the same conditions of dietary and fluid intake the urine samples of the patients with stone formation were more supersaturated with calcium oxalate (P less than 0.001) and had lower concentrations of protective inhibitors of crystallization (P less than 0.001) than those of the controls. However, the best separation between the groups was defined by a discriminant line relating inhibitory activity and urine saturation. A measure of the risk of forming large crystals, the saturation-inhibition index, was defined as the distance of each urine from the discriminant line. The patients with stone formation had a significantly higher mean saturation-inhibition index than the controls (P less than 0.001). Both the percentage of large calcium oxalate crystals excreted (P less than 0.001) and the stone episode rate (P less than 0.005) were significantly correlated with the saturation-inhibition index.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1244550     DOI: 10.1056/NEJM197601292940504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  44 in total

1.  Can a relationship reflect the risk of calcium oxalate urolithiasis?

Authors:  P Roca; A Conte; T Riera; F Grases
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  The use of risk indices: do they predict recurrence?

Authors:  Roger A L Sutton
Journal:  Urol Res       Date:  2006-01-06

Review 3.  The use of risk indices: do they predict recurrence? Yes, they (at least some) do.

Authors:  Norbert Laube; Michael Pullmann
Journal:  Urol Res       Date:  2006-01-06

4.  Investigations on macromolecular precipitation inhibitors of calcium oxalate.

Authors:  P Schnierle; F Sialm; H G Seiler; F Hering; G Rutishauser
Journal:  Urol Res       Date:  1992

5.  Design of a suitable formulation of FK613, a novel antiallergic agent, based on its pharmacokinetic and pharmacodynamic properties in healthy subjects.

Authors:  T Uematsu; S Nagashima; H Inaba; T Kajiho; H Kageyama; A Sugiyama; M Nakashima
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

6.  Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.

Authors:  P Schnierle; F Hering; H Seiler
Journal:  Urol Res       Date:  1996

7.  Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.

Authors:  Steeve Doizi; John R Poindexter; Margaret S Pearle; Francisco Blanco; Orson W Moe; Khashayar Sakhaee; Naim M Maalouf
Journal:  J Urol       Date:  2018-07-20       Impact factor: 7.450

8.  Urine saturation with calcium salts in normal subjects and idiopathic calcium stone-formers estimated by an improved computer model system.

Authors:  M Marangella; P G Daniele; M Ronzani; S Sonego; F Linari
Journal:  Urol Res       Date:  1985

9.  Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.

Authors:  Jack G Kleinman; Laura J Alatalo; Ann M Beshensky; Jeffrey A Wesson
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

10.  Clinical risk index in urolithiasis.

Authors:  Y M Fazil Marickar; Abiya Salim
Journal:  Urol Res       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.